期刊文献+

β肾上腺素能受体基因多态性与大动脉僵硬度的相关分析 被引量:2

Correlation between beta-adrenoceptor gene polymorphism and large-artery stiffness
下载PDF
导出
摘要 目的:β肾上腺素能受体(β-adrenoceptor,β-AR)包括β1,β2和β33种亚型,分析其基因多态性与大动脉僵硬度的关系。方法:试验于2003-02/2004-09在重庆医科大学生物医学工程研究室进行。选择在重庆医科大学体检的健康受试者94名,男49名,女45名,对试验均知情同意。测试受试者平卧位的血压,然后计算脉压差(脉压差可反应大动脉僵硬度)。用聚合酶链反应-限制性片段长度多态性技术和等位基因特异性聚合酶链反应法分析β1-AR的Ser49Gly和Arg389Gly,β2-AR的Arg16Gly和Gln27Glu,β3-AR的Trp64Arg基因多态性,并分析其基因多态性与脉压差的相关性。结果:94名受试者全部进入结果分析。①β2-AR的Arg16Gly基因多态性与脉压差有显著相关性(P<0.05),其中Arg/Gly杂合子基因型携带者的脉压差值最大(49.64±9.99)mmHg(1mmHg=0.133kPa),Arg/Arg纯合子基因型携带者的脉压差值最小(43.70±9.88)mmHg,而Gly/Gly纯合子基因型携带者的脉压差值居中(46.00±12.12)mmHg。②β1-AR的Ser49Gly和Arg389Gly、β2-AR的Gln27Glu和β3-AR的Trp64Arg基因多态性与脉压差无关(P>0.05)。结论:β2-AR的Arg16Gly基因多态性与脉压差值有显著相关性,故而β2-AR的Arg16Gly基因多态性与大动脉僵硬度有相关性。 AIM: To analyze the correlation between β-adrenoceptor (β-AR), including three subgroups: β1, β2 and β3, gene polymorphism and largeartery stiffness. METHODS: The experiment was conducted in the Biomedical Engineering Laboratory of Chongqing University of Medical Science from February 2003 and September 2004. Ninety-four healthy examinees (male 49; female 45) for physical examination were selected. All the people were informed and agreed to join the experiment. The blood pressures of the subjects in the supine were detected, and then the pulse pressure (reflected the stiffness of large artery) was computed. Polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) and allele specificPCR techniques were used to determine the polymorphism of Ser49Gly and Arg389Gly of the β1-AR gene, Arg16Gly and Gln27Glu of β2-AR gene and Trp64Arg of β3-AR gene and explore the correlation with pulse pressure. RESULTS: All the 94 subjects were involved in the result analysis.① The Argl6Gly polymorphism of β2-AR gene was significantly associated with pulse pressure (P 〈 0.05). Individuals with Arg/Gly heterozygote had the biggest pulse pressure (49.64±9.99) mm Hg, with Arg/Arg homozygote had the smallest pulse pressure (43.70±9.88) mm Hg, and the individuals with Gly/Gly homozygote had the intermediate pulse pressure (46.00±12.12) mm Hg. ②No association was found between Ser49Gly, Arg389Gly, Gln27Glu and Trp64Arg polymorphisms with pulse pressure, respectively (P〉 0.05). CONCLUSION: Arg16Gly polymorphism of β2-AR gene is significantly associated with pulse pressure. Therefore, Arg16Gly polymorphism of β2- AR gene has correlation with large-artery stiffness.
出处 《中国临床康复》 CSCD 北大核心 2006年第48期22-24,共3页 Chinese Journal of Clinical Rehabilitation
基金 重庆市科委基金资助项目([1999]-18-58) 重庆医科大学创新基金资助项目(CX200202)~~
  • 相关文献

参考文献15

  • 1Zakopoulos NA,Lekakis JP,Papamichael CM,et al.Pulse pressure in normotensives:a marker of cardiovascular disease.Am J Hypertens 2001; 14(3):195-9
  • 2Franklin SS.Pulse pressure as a risk factor.Clin Exp Hypertens 2004;26(7-8):645-52
  • 3关德明.脉压对心脑血管疾病的预报价值[J].中华流行病学杂志,2004,25(8):723-725. 被引量:5
  • 4Ichigi Y,Takano H,Umetani K,et al.Increased ambulatory pulse pressure is a strong risk factor for coronary endothelial vasomotor dysfunction.J Am Coll Cardiol 2005;45(9):1461-6
  • 5Powell JT,Turner RJ,Sian M,et al.Influence of fibrillin-1 genotype on the aortic stiffness in men.J Appl Physiol 2005;99(3):1036-40
  • 6Medley TL,Cole TJ,Gatzka CD,et al.Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease.Circulation 2002; 105(7):810-5
  • 7Bengtsson K,Melander O,Orho-Melander M,et al.Polymorphism in the beta(1)-adrenergic receptor gene and hypertension.Circulation 2001; 104(2):187-90
  • 8Maqbool A,Hall AS,Ball SG,et al.Common polymorphisms of beta1-adrenoceptor:identification and rapid screening assay.Lancet 1999;353(9156):897
  • 9O'Shaughnessy KM,Fu B,Dickerson C,et al.The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.Clin Sci (Lond) 2000;99(3).233-8
  • 10高光凯,蒋一平,王士雯.中国北方汉族人群β_2肾上腺素能受体基因多态性研究[J].中国优生与遗传杂志,2002,10(1):18-20. 被引量:11

二级参考文献16

  • 1Palaniappan L, Simons LA, Simons J, et al. Comparison of usefulness of systolic, diastolic, and mean blood pressure and pulse pressure as predictors of cardiovascular death in patients ≥60 years of age. The American Journal of Cardiology,2002,90:1398-140
  • 2Gerdts E, Palademetriou V, Palmieri V, et al. Correlates of pulse pressure reduction during antihypertensive treatment in hypertensive patients with electrocardiographic LHV. The American Journal of Cardiology, 2002,89: 399-402.
  • 3Dart AM,Kingwell BA. Pulse pressure a review of mechanisms and clinical relevance. Journal of the American College of Cardiology,2001,37: 975-984.
  • 4Jackson PR, Ramsay LE. First-line treatment for hypertension.European Heart Journal, 2002,23:179-182.
  • 5Roach D, Koshman ML, Duff H, et al. Induction of heart rate and blood pressure turbulence in the electrophysiologic laboratory. The American Journal of Cardiology,2002,90:1098-1102.
  • 6Taneja T,Kadish AH,Parker MA,et al. Acute blood pressure effects at the onset of supraventricular and ventricular tachycardia. The American Journal of Cardiology,2002,90:1294-1299.
  • 7Jonkowski P, Jaszcz KK, Czarnecka D, et al. Pulse pressure and restenosis after percutaneous coronary angioplasty. The American Journal of Cardiology,2002,90: 447-448.
  • 8Malmqvist K, Kahan T, Edner M, et al. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive LVH. The American Journal of Cardiology, 2002,90:1107-1112.
  • 9Bella JN,Devereux RB,Roman MJ, et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American indians. The American Journal of Cardiology, 2001,87:1260-1265.
  • 10Leeson CPM, Mann A, Kattenhorn M, et al. Relation between circulating n-3 fatty acid concentrations and endothelial function in early adulthood. European Heart Journal, 2002,23: 216-222.

共引文献14

同被引文献33

  • 1倪泉兴,张延龄.重视胰腺癌病人治疗后远期生存率的评估[J].外科理论与实践,2005,10(3):201-202. 被引量:4
  • 2Munakata M.Beta 2-adrenergic receptor gene polymorphisms.Nippon Rinsho 2001;59(10):1889-1893
  • 3Liu J,Liu ZQ,Yu BN,et al.beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.Clin Pharmacol Ther 2006;80(1):23-32
  • 4Masuo K,Katsuya T,Fu Y,et al.Beta2-and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.Circulation 2005;111(25):3429-3434
  • 5Abe Y,Yoshida T.Beta-adrenergic receptor gene polymorphism as a risk factor in the development of hypertensive organ damage.Nippon Rinsho 2004;62 Suppl 3:122-125
  • 6Bartosova L,Stmadova V,Bartos M,et al.Cardiovascular diseases and gene polymorphisms.Cas Lek Cesk 2006;145(9):695-700
  • 7lacoviello M,Folreo C,Sorrentino S,et al.Alpha-and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring.J Cardiovasc Med (Hagerstown) 2006;7(5):316-321
  • 8Ebina T,Kimura K,Toya Y,et al.beta-Adrenergic receptor gene.Nippon Rinsho 2006;64 Suppl 5:385-390
  • 9Matsuoka H,Iwama S,Miura N,et al.Impact of polymorphisms of human beta-adrenergic receptor gene on changes in height during growth hormone treatment.Endocr J 2002;49(1):21-28
  • 10Masuo K,Katsuya T,Fu Y,et al.Beta2-and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.Circulation 2005; 111(25):3429-3434

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部